SCHEMBL7354436

SCHEMBL7354436

CC1CC[C@@H]2C(=O)OC[C@@H]2C1

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7354431 1.00 ABCB1 (0.33) ABCB1
SCHEMBL23417055 0.86
SCHEMBL21185140 0.83
SCHEMBL13451412 0.83
SCHEMBL13398676 0.78 ABCB1 (0.33) ABCB1
SCHEMBL3778293 0.78
SCHEMBL23409268 0.78
SCHEMBL31084649 0.78
SCHEMBL14435544 0.75
SCHEMBL13309236 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6376539-B1 ANTIISCHEMIC AGENTS, CENTRAL NERVOUS SYSTEM DISORDERS BAYER AKTIENGESELLSCHAFT (DE) 2002-04-23 US disclosed
EP-1047686-A1 SUBSTITUTED BICYCLIC LACTONES Bayer Aktiengesellschaft (DE) 2000-11-02 EP disclosed
WO-1999036418-A1 SUBSTITUTED BICYCLIC LACTONES BAYER AKTIENGESELLSCHAFT (DE) 1999-07-22 WO disclosed